NNelo Trade
← Back to Market News
October 13, 2026 at 10:21 AM UTC

Nurix Therapeutics, Inc. reports financial results in SEC 8-K

Nurix Therapeutics, Inc. filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: October 13, 2026 at 10:19 AM UTC

Open official source